PDCD1 and neoplasm: Binding of kynurenine to AhR induces differentiation and activation of immunosuppressive T-regulatory cells (48–53), contributes to the recruitment of tolerogenic myeloid cells such as macrophages (54), and increases expression of the immune checkpoint molecule PD-1 on tumour-specific CD8+ T-cells (Figure 1) (55).